EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction

On Thursday, Scienture Holdings, Inc. (NASDAQ:SCNX) reported fiscal results for the 3rd quarter.

Net gross accrued from astir $65 1000 to $590 thousand, portion gross nett accrued from astir $4 1000 to $575 thousand.

"Q3 was a transformational 4th for Scienture arsenic we commenced income of Arbli," commented Narasimhan Mani, President and Co-CEO of Scienture.

Also Read: EXCLUSIVE: Scienture Launches Arbli Oral Suspension, Expanding Options For Hypertension Patients

After the extremity of the 3rd quarter, the institution strengthened its equilibrium expanse by substantially reducing outstanding indebtedness and importantly enhancing its currency presumption to implicit $8 cardinal arsenic of November 13, 2025.

"Having optimized our superior structure, we are present powerfully positioned and adequately capitalized to beforehand our commercialized and operational priorities," Mani said.

View much net connected SCNX

"Backed by a beardown commercialized infrastructure and the palmy motorboat of Arbli, Scienture is preparing to commercially motorboat Rezenopy, an opioid overdose exigency treatment, successful Q1 2026," stated Shankar Hariharan, Executive Chairman and co-CEO of Scienture.

"Additionally, our improvement pipeline remains strong, and we proceed to measure further opportunities to adhd accretive products to our commercialized portfolio," Hariharan commented connected Thursday.

Earlier this month, Scienture said that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has been added to the formularies of cardinal nationalist payors, expanding entree done some aggregate commercialized sum and Medicare supplement plans.

The inclusion extends availability to implicit 100 cardinal covered lives crossed the United States.

Price Action: SCNX banal is down 3.26% astatine $0.69 during the premarket league astatine the past cheque connected Thursday.

Read Next:

• Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker

Photo via Shutterstock

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click present to get apical commercialized ideas daily, positive unlimited entree to cutting-edge tools and strategies to summation an borderline successful the markets.

This nonfiction EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction primitively appeared connected Benzinga.com

© 2025 Benzinga.com. Benzinga does not supply concern advice. All rights reserved.